[go: up one dir, main page]

CL2018003075A1 - Composiciones nutritivas para la protección cardíaca en animales de compañía. - Google Patents

Composiciones nutritivas para la protección cardíaca en animales de compañía.

Info

Publication number
CL2018003075A1
CL2018003075A1 CL2018003075A CL2018003075A CL2018003075A1 CL 2018003075 A1 CL2018003075 A1 CL 2018003075A1 CL 2018003075 A CL2018003075 A CL 2018003075A CL 2018003075 A CL2018003075 A CL 2018003075A CL 2018003075 A1 CL2018003075 A1 CL 2018003075A1
Authority
CL
Chile
Prior art keywords
company
animal
pets
dmvd
cardiac protection
Prior art date
Application number
CL2018003075A
Other languages
English (en)
Inventor
Qinghong Li
Dorothy P Laflamme
Brittany Vester Boler
Xui Xu
Sandeep Bhatnagar
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of CL2018003075A1 publication Critical patent/CL2018003075A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A23K20/24—Compounds of alkaline earth metals, e.g. magnesium
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A23K20/30—Oligoelements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/48—Moist feed
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Mycology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

MÉTODO PARA TRATAR LA ENFERMEDAD DEGENERATIVA DE LA VÁLVULA MITRAL (DMVD) EN UN ANIMAL DE COMPAÑÍA QUE LA TIENE, MÉTODO PARA PREVENIR LA DMVD EN UN ANIMAL DE COMPAÑÍA EN RIESGO DE SUFRIRLA, Y MÉTODO PARA MANTENER O MEJORAR LA SALUD CARDÍACA EN UN ANIMAL DE COMPAÑÍA. INCLUYEN ADMINISTRAR A DICHO ANIMAL POR VÍA ORAL UNA COMPOSICIÓN QUE CONTIENE TRIGLICÉRIDOS DE CADENA MEDIA Y, OPCIONALMENTE, UNO O MÁS DE ÁCIDOS GRASOS OMEGA-3, VIT. E, LISINA, TAURINA, MAGNESIO O AMINOÁCIDOS QUE CONTIENEN AZUFRE.
CL2018003075A 2016-05-20 2018-10-29 Composiciones nutritivas para la protección cardíaca en animales de compañía. CL2018003075A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662339436P 2016-05-20 2016-05-20

Publications (1)

Publication Number Publication Date
CL2018003075A1 true CL2018003075A1 (es) 2018-12-07

Family

ID=58993169

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2018003075A CL2018003075A1 (es) 2016-05-20 2018-10-29 Composiciones nutritivas para la protección cardíaca en animales de compañía.

Country Status (15)

Country Link
US (1) US20170332686A1 (es)
EP (1) EP3458046B1 (es)
JP (1) JP6920343B2 (es)
CN (1) CN109069465B (es)
AU (1) AU2017267615B2 (es)
BR (1) BR112018072064B8 (es)
CA (1) CA3021169A1 (es)
CL (1) CL2018003075A1 (es)
ES (1) ES2851923T3 (es)
HU (1) HUE053622T2 (es)
MX (1) MX388553B (es)
NZ (1) NZ746681A (es)
PL (1) PL3458046T3 (es)
RU (1) RU2744134C2 (es)
WO (1) WO2017199223A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018219877A1 (en) * 2017-05-29 2018-12-06 Nestec S.A. Medium chain fatty acids for use in the prevention or treatment of cardiac enlargement and/or valvular heart disease
CA3081756A1 (en) 2017-11-17 2019-05-23 Hill's Pet Nutrition, Inc. Compositions comprising omega-3 polyunsaturated and medium chain fatty acids
AU2019280170B2 (en) * 2018-06-07 2024-03-28 Société des Produits Nestlé S.A. Methods and compositions for increasing ketone bodies in animals
EP3840749B1 (en) * 2018-08-22 2023-08-09 The J. David Gladstone Institutes, A Testamentary Trust Established under The Will of J. David Gladstone Compounds for treating cardiac valve disease
CN109007397A (zh) * 2018-08-23 2018-12-18 广东仁源生物科技有限公司 一种可以改善小鼠心脏形态结构与功能的饲料组合物及其制备方法
CN113227402A (zh) * 2018-12-27 2021-08-06 雀巢产品有限公司 用于诊断和治疗犬科动物的退行性二尖瓣疾病的组合物和方法
CA3128189A1 (en) * 2019-02-01 2020-08-06 Mars, Incorporated Feline food composition
CA3134246A1 (en) * 2019-03-22 2020-10-01 Societe Des Produits Nestle S.A. Methods using administration of medium chain triglycerides (mct) prior to a meal to increase ketone production from the mcts
EP3937653A1 (en) * 2019-05-31 2022-01-19 Société des Produits Nestlé S.A. Mct-based nutrition blend for providing health benefits in animals
EP3934441A1 (en) * 2019-05-31 2022-01-12 Société des Produits Nestlé S.A. Mct-based nutrition blend for providing health benefits in animals
GB201908111D0 (en) * 2019-06-06 2019-07-24 Mars Inc Modulation of the oral microbiota
EP4203699A1 (en) * 2020-12-22 2023-07-05 Hill's Pet Nutrition, Inc. Pet food compositions
KR102733845B1 (ko) * 2021-11-10 2024-11-27 문창민 반려동물의 무기력증, 식욕부진, 및 불안 장애 개선용 간식 및 이의 제조방법
KR102733841B1 (ko) * 2021-11-10 2024-11-27 문창민 반려동물의 눈 건강 개선용 간식 및 이의 제조방법
KR102733843B1 (ko) * 2021-11-10 2024-11-27 문창민 반려동물의 피부 건강 개선용 간식 및 이의 제조방법

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920098A (en) * 1986-09-17 1990-04-24 Baxter International Inc. Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic vascular, cardiovascular, and/or thrombotic diseases
AU784852B2 (en) * 2001-08-10 2006-07-06 Mars, Incorporated Canine support diet
US7514107B2 (en) * 2002-03-21 2009-04-07 Mars, Incorporated Treatment of diseases involving defective gap junctional communication
JP2005047851A (ja) * 2003-07-29 2005-02-24 Nisshin Pharma Inc ユビデカレノン含有組成物
ES2392581T3 (es) * 2003-09-05 2012-12-12 Hill's Pet Nutrition, Inc. Composición para consumo animal
EP1794316B1 (en) * 2004-08-30 2018-10-03 Hill's Pet Nutrition, Inc. Genome-based diet design
US7595079B2 (en) * 2005-07-08 2009-09-29 Bomac Vets Plus, Inc. Nutritional conjunctive support therapy for recovery in animals following stress or illness
RU2437656C2 (ru) * 2005-12-15 2011-12-27 Нестек С.А. Композиции и способы для сохранения функции головного мозга
EP2044930A1 (en) * 2007-10-01 2009-04-08 Nestec S.A. Composition for controlling lipase catalyzed reactions
AU2008345571B2 (en) * 2007-12-21 2011-10-13 Hill's Pet Nutrition, Inc. Pet food composition
JP5513852B2 (ja) * 2009-11-05 2014-06-04 花王株式会社 犬の僧帽弁閉鎖不全症及び／又は三叉弁閉鎖不全の発症リスク低減方法
WO2012037328A2 (en) * 2010-09-17 2012-03-22 Maine Natural Health, Inc. Compositions containing omega-3 oil with an anti-inflammatory agent and uses thereof
BR112013026706A2 (pt) * 2011-04-18 2016-12-27 Nestec Sa composições nutricionais compreendendo ácido alfa-hidroxi-isocaproico
FR2982460B1 (fr) * 2011-11-14 2016-08-05 Virbac Sa Produits pour administration orale comprenant des extraits de grenade punica granatum, destines a un animal de compagnie, et ses applications
US20140171415A1 (en) * 2012-12-14 2014-06-19 Boehringer Ingelheim Vetmedica Gmbh Funny current (if) inhibitors for use in a method of treating and preventing heart disease in canine
JP2014210761A (ja) * 2013-04-05 2014-11-13 株式会社シバヤギ 抗イヌｎ末端プロ心房性ナトリウム利尿ペプチド抗体ならびにそれを用いた免疫学的測定方法、および免疫学的測定用キット
WO2014196957A1 (en) * 2013-06-03 2014-12-11 Nestec Sa Methods for diagnosing chronic valvular disease
ES2617035T3 (es) * 2013-06-28 2017-06-15 Nestec S.A. Composiciones y métodos para aumentar el rendimiento deportivo

Also Published As

Publication number Publication date
BR112018072064B1 (pt) 2022-07-26
CN109069465B (zh) 2021-08-17
RU2018145067A3 (es) 2020-09-11
MX2018014083A (es) 2019-04-04
CN109069465A (zh) 2018-12-21
AU2017267615A1 (en) 2018-10-18
RU2018145067A (ru) 2020-06-22
HUE053622T2 (hu) 2021-07-28
NZ746681A (en) 2022-07-01
RU2744134C2 (ru) 2021-03-03
AU2017267615B2 (en) 2022-03-17
BR112018072064B8 (pt) 2022-08-23
EP3458046B1 (en) 2021-01-13
US20170332686A1 (en) 2017-11-23
WO2017199223A1 (en) 2017-11-23
PL3458046T3 (pl) 2021-07-05
JP2019521646A (ja) 2019-08-08
CA3021169A1 (en) 2017-11-23
JP6920343B2 (ja) 2021-08-18
EP3458046A1 (en) 2019-03-27
BR112018072064A2 (pt) 2019-02-12
ES2851923T3 (es) 2021-09-09
MX388553B (es) 2025-03-20

Similar Documents

Publication Publication Date Title
CL2018003075A1 (es) Composiciones nutritivas para la protección cardíaca en animales de compañía.
SV2018005781A (es) Proteinas de fusión gdf15 y usos de éstas
MX2017008698A (es) Composiciones multi-suplementos.
MX388267B (es) Mitigantes quimicos en alimento para animales e ingredientes alimentarios.
CL2012002423A1 (es) Método para tratar lupus nefritis activo que comprende administrar al paciente laquinimod o su sal sódica por vía oral; composición farmacéutica que comprende laquinimod y micofenolato mofetil.
CR20160212A (es) Composiciones y métodos para modular los receptores x farnesoides
BR112019025388A2 (pt) Suplemento de ração animal, composição de ração animal, usos de um suplemento de ração animal, métodos para produzir um suplemento de ração animal e para produzir uma composição de ração animal
CL2016000621A1 (es) Formulación que comprende un adenovirus recombinante un tampón citrato hidroxipropil-beta-ciclodextrina una sal un detergente no iónico en la que dicha formulación tiene un ph que oscila entre 5.5-6,5. método de conservación de un adenovirus
MX385747B (es) Composiciones y métodos para modular la microflora gastrointestinal en un canino.
MX2017013875A (es) Ciertos inhibidores de la proteína quinasa.
CL2015003468A1 (es) Composicion solida para administracion oral conteniendo acido ibandronico o una sal farmaceuticamente aceptable del mismo y vitamina d.
IL286733A (en) Compound, method and pharmaceutical composition for dux4 expression adjustment
CL2019000032A1 (es) Uso de oxido de aleno sintasa para la preservación de semen y la reproducción asistida (divisional solicitud 201603067)
AR112409A1 (es) Composiciones capilares para tratamiento del daño
AR108291A1 (es) Composición de nanoemulsión
CL2017000873A1 (es) Composiciones y métodos para mejorar la movilidad o actividad o tratar la fragilidad
MX386374B (es) Composiciones farmacéuticas y alimenticias para inducir la saciedad y prolongar la saciedad en sujetos que lo necesiten.
MX2019012681A (es) Composiciones nutricionales y farmaceuticas encapsuladas.
MX2016015961A (es) Composiciones farmacéuticas que comprenden ácido dihomo-gamma-linolénico (dgla) y uso de las mismas.
CL2019002325A1 (es) Combinaciones farmacéuticas para tratar cáncer.
CL2017001472A1 (es) Composiciones y métodos que comprenden triglicéridos de cadena media para el tratamiento de la epilepsia.
MX2018015884A (es) Composiciones y metodos para caninos pequeños.
CR20120134A (es) Derivados de pirazol que modulan la estearoil-coa-desaturasa
MX2022015141A (es) Composiciones y metodos de uso de un compuesto de control de inapetencia.
MX2016016928A (es) Composiciones parasiticidas que comprenden derivados de indol, metodos y usos de los mismos.